Application deadline 30 June 2026

Science Meets Strategy – A Decade of Innovation, Collaboration and Impact HTW Berlin – University of Applied Sciences marked a decade of its international Master's programme MBA & Engineering in Life Science Management (LSM) by bringing together…

Michael Gotthardt and his team have discovered a previously unknown genetic switch that affects RBM20, an important protein in heart cells. The findings, published in ​“Nature Communications,” suggest a potential new target for treating…

EU project aims to make breakthrough in sustainable chemical manufacture

Early-stage and incorporated high-potential AI startups based in Germany can now apply for the next AI Nation Grant and the next AI Nation Accelerator batch.

T-CURX acquires Pantherna Therapeutics to leverage the complementary expertises and proprietary technologies of both companies to accelerate clinical translation of CAR-T strategies with a clear focus on clinical validation of in vivo CAR-T…

Eckert & Ziegler SE (ISIN DE0005659700) has won the “Best Managed Companies Award” for the third time in a row. With this honor, Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federation of German Industries (BDI) recognize…

A combination of three drugs appears to more effectively treat people with cystic fibrosis than therapy with only two, concludes a study by Max Delbrück Center researchers published in ​“Cell Systems.” The study analyzed changes in the proteomes of…

Eckert & Ziegler SE (ISIN DE0005659700), a world-leading specialist in isotope-related components, equipment and services for nuclear medicine and radiation therapy, today signed a collaboration and supply agreement with Thor Medical, a leading…

Different types of bone marrow stem cells give rise to blood and immune cells. A team led by Simon Haas now reports in “Nature Cell Biology” how that diversity develops. The findings could help improve stem cell therapies, including treatments for…